| Authors: |
Lang AE; University Health Network's Krembil Brain Institute, Edmond J Safra Program in Parkinson's Disease and the Rossy PSP Centre, Toronto Western Hospital, Toronto, ON M5T 2S8, Canada. Electronic address: anthony.lang@uhn.ca., Höglinger GU; Department of Neurology, University Hospital, LudwigMaximilians-University (LMU) and German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Adler CH; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA., Berg D; Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Klein C; Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lüebeck, Germany., Outeiro TF; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Poewe W; Medical University Innsbruck, Innsbruck, Austria., Postuma R; Department of Neurology, McGill University, Montreal Neurological Institute, Montreal, QC, Canada., Stoessl AJ; Pacific Parkinson's Research Centre and Parkinson's Foundation Centre of Excellence, University of British Columbia, BC, Canada. |
